phosphodiesterase type 5 inhibitors
Showing 1 - 25 of >10,000
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Pulmonary Hypertension, COPD Trial (Tadalafil)
Not yet recruiting
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Apr 25, 2023
Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)
Not yet recruiting
- Single-ventricle
- +2 more
- Sildenafil
- Placebos
- (no location specified)
Jan 20, 2022
Erectile Dysfunction Trial in Garches (Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH), Placebo
Recruiting
- Erectile Dysfunction
- Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH)
- Placebo administration
-
Garches, FranceNeuro-Urology-Andrology, Physical Medicine and Rehabilitation De
Mar 28, 2022
Erectile Dysfunction Trial in Banha (OnabotulinumtoxinA, Trimix)
Recruiting
- Erectile Dysfunction
- OnabotulinumtoxinA
- Trimix
-
Banha, Kalubiaya, EgyptBanha University Hospitals
Jan 6, 2022
Carotid Artery Intima Media Thickness Can Predict Response to
Completed
- Erectile Dysfunction Due to Arterial Disease
- CIMT (Carotid artery intima media thickness measurement)
-
Bursa, TurkeyBursa Yuksek Ihtisas Training and Research Hospital
Jan 11, 2023
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Phosphodiesterase Type 5 Inhibitor to Improve Anabolic
Not yet recruiting
- Sarcopenia
- Tadalafil 5mg
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jul 25, 2022
Diabete Type 2 Trial in El Sadat (Sitagliptin 50 mg, Empagliflozin 12.5 MG, Sitagliptin 50 mg + Empagliflozin 12.5 MG)
Completed
- Diabete Type 2
- Sitagliptin 50 mg
- +3 more
-
El Sadat, EgyptUniversity of Sadat City
Apr 27, 2022
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Glaucoma Trial in London (Sildenafil 100mg)
Suspended
- Glaucoma
- Sildenafil 100mg
-
London, United KingdomWestern Eye Hospital
Jan 21, 2021
Sickle Cell People With Pulmonary Hypertension
Completed
- Pulmonary Hypertension
- Sickle Cell Disease
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 16, 2021
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In
Completed
- Erectile Dysfunction
- (no location specified)
Jan 28, 2021
Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in
Completed
- Diabetes Mellitus, Type 2
- Subjects treated with Empagliflozin or any Sodium-glucose cotransporter-2 (SGLT-2) inhibitor
- Subjects treated with Dipeptidyl peptidase-4 (DPP-4) inhibitor
-
Gentofte, Denmark
- +12 more
Jan 18, 2022
Cystic Fibrosis Trial in Denver, Augusta (Sildenafil 40mg oral capsule, Placebo Oral capsule)
Recruiting
- Cystic Fibrosis
- Sildenafil 40mg oral capsule
- Placebo Oral capsule
-
Denver, Colorado
- +1 more
Aug 29, 2022
Sirolimus Eluting Balloon Utilization for Treatment of
Recruiting
- Erectile Dysfunction
- Endovascular procedure
-
Roma, Lazio, ItalyPoliclinico Tor Vergata
Dec 27, 2022
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy Trial in Nashville (Theophylline, Placebos)
Recruiting
- Pseudohypoparathyroidism
- Albright Hereditary Osteodystrophy
- Theophylline
- Placebos
-
Nashville, TennesseeAshley Shoemaker
Aug 15, 2022
Chronic Thromboembolic Pulmonary Hypertension, CTEPH Trial (Pulmonary endarterectomy, Balloon pulmonary angioplasty, Pulmonary
Not yet recruiting
- Chronic Thromboembolic Pulmonary Hypertension
- CTEPH
- Pulmonary endarterectomy
- +2 more
- (no location specified)
Nov 29, 2022
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a Trial in Nashville (Theophylline,
Recruiting
- Pseudohypoparathyroidism
- +2 more
- Theophylline
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 4, 2022
Diabetic Cardiomyopathy, Diabetes Type 2 Trial in Rome (Tadalafil, Placebo)
Completed
- Diabetic Cardiomyopathy
- Diabetes Mellitus Type 2
- Tadalafil
- Placebo
-
Rome, ItalyDipartimento di Medicina Sperimentale - Sezione di Fisiopatologi
Jul 9, 2019
Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)
Completed
- Pulmonary Arterial Hypertension
- Riociguat (Adempas, BAY63-2521)
- +2 more
-
Phoenix, Arizona
- +80 more
Feb 3, 2021
Cardiomyopathy, Renal Impairment Trial in Rochester (Tadalafil, Placebo)
Completed
- Cardiomyopathy
- Renal Impairment
- Tadalafil
- Placebo
-
Rochester, MinnesotaMayo Clinic
Jun 4, 2021
Heart Defects, Congenital, Transposition of Great Vessels With Ventricular Inversion Trial in Austria, Switzerland (Tadalafil 20
Completed
- Heart Defects, Congenital
- Transposition of Great Vessels With Ventricular Inversion
- Tadalafil 20 MG
- Placebo 20 MG
-
Wien, Austria
- +6 more
Feb 23, 2022
COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)
Terminated
- COVID 19
- +14 more
- Linagliptin 5 MG
-
Be'er Ya'aqov, Israel
- +2 more
May 28, 2021
Erectile Dysfunction, Lower Urinary Tract Symptoms Trial in Mansoura (Tadalafil 5mg)
Active, not recruiting
- Erectile Dysfunction
- Lower Urinary Tract Symptoms
- Tadalafil 5mg
-
Mansoura, Dakahlia, EgyptUrology and Nephrology Center
Jul 18, 2023